Banque Cantonale Vaudoise Regeneron Pharmaceuticals, Inc. Transaction History

Banque Cantonale Vaudoise

$2.27 Billion
Q1 2025

A detailed history of Banque Cantonale Vaudoise transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 2,574 shares of REGN stock, worth $1.55 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,574

Previous 817 215.06%

Holding current value

$1.55 Million

Previous $858,000 90.33%

% of portfolio

0.07%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$634.14 - $744.83 $1.11 Million - $1.31 Million	1,757 Added 215.06%	2,574 $1.63 Million
Q3 2024 Nov 08, 2024	SELL	$1024.09 - $1201.76 $635,959 - $746,292	-621 Reduced 43.18%	817 $858,000
Q2 2024 Jul 31, 2024	SELL	$883.2 - $1071.19 $2.85 Million - $3.45 Million	-3,225 Reduced 69.16%	1,438 $1.51 Million
Q1 2024 Apr 10, 2024	BUY	$902.69 - $993.35 $1.05 Million - $1.16 Million	1,167 Added 33.38%	4,663 $4.49 Million
Q4 2023 Feb 07, 2024	SELL	$775.18 - $881.7 $311,622 - $354,443	-402 Reduced 10.31%	3,496 $3.07 Million
Q3 2023 Nov 08, 2023	BUY	$692.45 - $844.37 $214,659 - $261,754	310 Added 8.64%	3,898 $3.21 Million
Q2 2023 Aug 09, 2023	SELL	$700.03 - $830.35 $1.88 Million - $2.23 Million	-2,688 Reduced 42.83%	3,588 $2.58 Million
Q1 2023 Apr 20, 2023	BUY	$680.49 - $826.97 $2.5 Million - $3.03 Million	3,670 Added 140.83%	6,276 $5.16 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $1.45 Million - $1.58 Million	-2,059 Reduced 44.14%	2,606 $1.88 Million
Q3 2022 Oct 17, 2022	SELL	$573.97 - $724.32 $5,739 - $7,243	-10 Reduced 0.21%	4,665 $3.21 Million
Q2 2022 Aug 02, 2022	BUY	$548.35 - $738.84 $868,038 - $1.17 Million	1,583 Added 51.2%	4,675 $2.76 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $1.23 Million - $1.45 Million	-2,075 Reduced 40.16%	3,092 $2.16 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $871,741 - $1.08 Million	1,604 Added 45.02%	5,167 $3.26 Million
Q3 2021 Oct 29, 2021	SELL	$574.03 - $680.96 $125,712 - $149,130	-219 Reduced 5.79%	3,563 $2.16 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $63,828 - $75,402	135 Added 3.7%	3,782 $2.11 Million
Q1 2021 May 11, 2021	BUY	$446.73 - $548.2 $189,860 - $232,985	425 Added 13.19%	3,647 $1.73 Million
Q4 2020 Feb 05, 2021	SELL	$478.3 - $607.98 $205,669 - $261,431	-430 Reduced 11.77%	3,222 $1.56 Million
Q3 2020 Oct 30, 2020	SELL	$544.75 - $658.21 $837,825 - $1.01 Million	-1,538 Reduced 29.63%	3,652 $2.04 Million
Q2 2020 Jul 22, 2020	BUY	$493.32 - $643.92 $1.33 Million - $1.74 Million	2,695 Added 108.02%	5,190 $3.24 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $417,871 - $614,576	1,243 Added 99.28%	2,495 $1.22 Million
Q4 2019 Feb 10, 2020	BUY	$274.13 - $376.51 $343,210 - $471,390	1,252 New	1,252 $471,000

Others Institutions Holding REGN

# of Institutions

1,469

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $64.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Regeneron Pharmaceuticals, Inc. Transaction History